On December 1, 2025, the Office of the United States Trade Representative, the Department of Commerce, and the Department of Health and Human Services announced an agreement with the United Kingdom (U ...
Rep. Anna Paulina Luna (R-Fla.) is “hopeful” Congress will codify President Trump’s executive order on capping prescription ...
The MFN executive order seeks to align US drug prices with those in other developed countries, recently advancing through a voluntary agreement with Pfizer. Legal and procedural challenges exist, with ...
New demands to follow the most favored nation executive order could lead to some compliance but it is unknown just how effective they will be across all health care. In the second part of her Q&A, ...
The White House on Friday announced it has struck a deal with AstraZeneca after the drugmaker agreed to lower prices and sell medications to Medicaid at “most favored nation” prices. The ...
Sen. Ruben Gallego (D-Ariz.) is raising concerns over the lack of details given about President Trump’s “most favored nation” (MFN) pricing deal he announced with Pfizer this week, calling on the ...
GlobalData on MSN
Pharma positions itself for 2026 amid an evolving US landscape
From tariffs and onshoring to MFN, the US has seen significant policy developments - but how will these impact pharma in 2026 ...
The White House announced Friday that nine additional pharmaceutical companies have agreed to follow President Trump’s Most Favored Nation (MFN) drug pricing policy, with several of the companies ...
The Trump administration on Tuesday announced plans to launch TrumpRx.com, an online platform that it says will direct Americans to lower-priced drugs. The announcement came one day after President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback